– Reuters Citing Tasnim
Tenax Therapeutics Announces Pricing Of ~$15.6M Public Offering
Tenax Therapeutics, Inc. (NASDAQ:TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high